The system, which has received CE Mark approval in Europe, adds to an increasingly crowded field of PFA technologies.

Pulse Biosciences is developing nsPFA technology for cardiac ablation to treat AFib and for ablating benign thyroid nodules.

Researchers from Queen Mary University of London have developed an AI tool that creates synthetic yet medically accurate models of fibrotic heart tissue (heart scarring), aiding treatment planning for ...

Abbott designed the Volt PFA catheter for maneuverability, efficient ablation and thermal risk mitigation, said Dr.

Atrial fibrillation is frequently treated with ablation -- a procedure where doctors create small, controlled scars to block erratic electrical signals. However, success rates vary considerably ...

One of AI’s most immediate impacts is in screening and identifying patients who may have asymptomatic or paroxysmal AF, those ...

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac arrhythmias, announced the continuation of the Quick AF study, which evaluates the investigational ...

CardioFocus announced the completion of clinical cases with its QuickShot Nav large-area focal pulsed field ablation (PFA) ...

Recent study results suggest that atrial fibrillation increases the risk of dementia and that the risk association is ...

Jackson-Madison County General Hospital now offers a new therapy to treat patients with advanced atrial fibrillation, who ...

A novel diffusion model generates synthetic atrial fibrosis images to augment data for deep learning, improving prediction of ...

Johnson & Johnson’s electrophysiology unit struggled in the first quarter, as the company chases Medtronic and Boston ...